Costly GLP-1 Drugs are Rarely Covered for Weight Loss by Marketplace Plans For Drugs Used to Treat Diabetes, Plans Almost Always Require Prior Authorization or Other Utilization Management Affordable Care Act (ACA) Marketplace plans rarely cover GLP-1 drugs approved solely for obesity treatment, according to a new KFF analysis of 2024 federal plan data
If youve ever cut your calories to the bone and doubled your cardio, only to see the scale refuse to budge, you aren't failing
In a Swiss study (11), almost half of all general practitioners agreed with prescribing B12 for unexplained fatigue, even though theres not much research to bear it out
The disadvantage is that finger-prick samples are sometimes insufficient for all tests, and some patients find the collection process uncomfortable
In this international review, researchers assessed 22 studies involving 1,995 adults who were classified as overweight (with a body mass index of 2529.9 kg/m) or obese (with a BMI of 30 kg/m or above) to assess the effectiveness of intermittent fasting for up to 12 months
As GLP-1 adoption grows, retail CMBS investors and REITs will watch tenant credit, traffic, and category performance more closely